Providing Today's Patients with Medicines of the Future
Simcere Project X, only for “daring explorers”!
On June 13, 2022, Simcere Pharma (2096.HK) announced that a global multi-center pivotal Phase 3 clinical trial (PRESERVE1 study) of Trilaciclib, an in...
The 2022 annual meeting of American Society of Clinical Oncology (ASCO) held in Chicago and online in June 3-7, 2022 (EST) is attracting global attent...
On May 31, 2022, Simcere Pharmaceuticals (2096.HK) released the 2021 Environmental, Social and Governance (ESG) Report. This report comprehensively sh...
On May 27, 2022, Simcere Pharmaceuticals (2096.HK) announced that, SIM0335 (CKBA ointment), an innovative chemical drug candidate developed in-house b...
Staff
Current Brands of Products
Innovative Product Candidates
Covering Class III Hospitals
Covering Other Hospitals & Medical Institutions